Skip to main content

Table 2 Valuation of the B2C telemonitoring venture in the fifth year (in million US dollars)

From: Assessment of a Business-to-Consumer (B2C) model for Telemonitoring patients with Chronic Heart Failure (CHF)

Country

Discount

Annual cash flow (profit/loss)

Present value of annual cash flow

Present value of all annual cash flows

Present value of terminal valuea

Total present valueb

Singapore

50% annually

3.13

0.41

1.51

4.13

5.64

25% annually

3.13

1.03

3.15

10.27

13.41

15% annually

3.13

1.56

4.42

15.58

20.00

Netherlands

50% annually

10.76

1.42

6.06

14.17

20.23

25% annually

10.76

3.53

12.12

35.27

47.39

15% annually

10.76

5.35

16.80

53.51

70.31

USA

50% annually

−94.76

0

0

0

0

25% annually

−94.76

0

0

0

0

15% annually

−94.76

0

0

0

0

  1. a Terminal value calculated as ×10 annual cash flow in the fifth year
  2. b Sums not matching due to rounding